Similar articles

• Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.

  Garassino MC, Crinò L, Catino A, Ardizzoni A, Cortesi E, Cappuzzo F, Bordi P, Calabrò L, Barbieri F, Santo A, Altavilla G, Ambrosio F, Mini E, Vasile E, Morgillo F, Scoppola A, Bengala C, Follador A, Tedde N, Giannarelli D, Lo Russo G, Vitiello F. Garassino MC, et al. Tumour Biol. 2018 Nov;40(11):1010428318815047. doi: 10.1177/1010428318815047. Tumour Biol. 2018. PMID: 30486741
• Sequential CT Findings in Patients With Non-small-cell Lung Cancer Receiving Nivolumab.

  Johnson DY, Short RG, Patz EF Jr. Johnson DY, et al. Clin Lung Cancer. 2018 Mar;19(2):175-180. doi: 10.1016/j.cllc.2017.10.009. Epub 2017 Oct 28. Clin Lung Cancer. 2018. PMID: 29153896
• Nivolumab in advanced non-small-cell lung cancer patients who failed prior platinum-based chemotherapy.

  Lee JS, Lee KH, Cho EK, Kim DW, Kim SW, Kim JH, Cho BC, Kang JH, Han JY, Min YJ, Park K. Lee JS, et al. Lung Cancer. 2018 Aug;122:234-242. doi: 10.1016/j.lungcan.2018.05.023. Epub 2018 May 24. Lung Cancer. 2018. PMID: 30032838 Clinical Trial.
• Nivolumab: a review in advanced squamous non-small cell lung cancer.

  Keating GM. Keating GM. Drugs. 2015 Nov;75(16):1925-34. doi: 10.1007/s40265-015-0492-9. Drugs. 2015. PMID: 26514815 Review.
• Nivolumab in the treatment of metastatic squamous non-small cell lung cancer: a review of the evidence.

  Lim JS, Soo RA. Lim JS, et al. Ther Adv Respir Dis. 2016 Oct;10(5):444-54. doi: 10.1177/1753465816661091. Epub 2016 Jul 31. Ther Adv Respir Dis. 2016. PMID: 27480166 Free PMC article. Review.